AMGN:NGS-Amgen Inc. (USD)

EQUITY | Drug Manufacturers - General | Nasdaq Global Select

Last Closing

USD 285.98

Change

0.00 (0.00)%

Market Cap

USD 107.37B

Volume

3.47M

Analyst Target

USD 262.76
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Amgen Inc is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. The Company's business segment is human therapeutics.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

+1.72 (+2.59%)

USD 240.59B
GILD Gilead Sciences Inc

+2.87 (+2.77%)

USD 133.70B
SNY Sanofi ADR

+0.34 (+0.66%)

USD 125.78B
BIIB Biogen Inc

+4.09 (+3.55%)

USD 18.00B
GRFS Grifols SA ADR

+0.24 (+3.55%)

USD 7.13B
AMRN Amarin Corporation PLC

+0.17 (+1.83%)

USD 0.19B
MIRA MIRA Pharmaceuticals, Inc. Com..

+0.03 (+2.90%)

USD 0.02B
SCLX Scilex Holding Company

-0.01 (-3.88%)

N/A
SCLXW Scilex Holding Company

-0.05 (-42.22%)

N/A

ETFs Containing AMGN

2B70:F iShares NASDAQ US Biotech.. 8.87 % 0.00 %

+0.15 (+0.85%)

USD 0.52B
BTEC:SW iShares Nasdaq US Biotech.. 7.89 % 0.00 %

+0.28 (+0.85%)

N/A
UBIO 6.41 % 0.95 %

N/A

N/A
MEDX Horizon Kinetics Medical .. 5.91 % 0.00 %

+0.34 (+0.85%)

N/A
DOGG First Trust Exchange-Trad.. 5.62 % 0.00 %

+0.22 (+0.85%)

USD 0.03B
LIFE:CA Evolve Global Healthcare .. 5.62 % 0.69 %

+0.26 (+0.85%)

CAD 0.22B
FHI-B:CA CI Health Care Giants Cov.. 5.47 % 0.00 %

N/A

CAD 0.05B
LIFE-B:CA Evolve Global Healthcare .. 5.45 % 0.00 %

+0.33 (+0.85%)

N/A
THNR Amplify ETF Trust 5.16 % 0.00 %

+0.48 (+0.85%)

USD 3.45M
ZWHC:CA BMO Covered Call Health C.. 5.07 % 0.00 %

+0.20 (+0.85%)

N/A
NDJI 4.95 % 0.00 %

N/A

N/A
LIFE-U:CA Evolve Global Healthcare .. 4.94 % 0.00 %

N/A

N/A
YALL God Bless America ETF 4.70 % 0.00 %

+0.48 (+0.85%)

N/A
OZEM Roundhill GLP-1 & Weight .. 4.63 % 0.00 %

+0.84 (+0.85%)

USD 0.04B
DJIA Global X Dow 30 Covered C.. 4.53 % 0.00 %

+0.19 (+0.85%)

USD 0.12B
CBUF:F iShares V Public Limited .. 4.40 % 0.00 %

N/A

N/A
SXRU:F iShares Dow Jones Indust .. 4.36 % 0.00 %

+2.15 (+0.85%)

USD 1.42B
CSINDU:SW iShares VII PLC - iShares.. 4.29 % 0.00 %

+14.20 (+0.85%)

USD 1.59B
WHCS:SW iShares MSCI World Health.. 4.21 % 0.00 %

N/A

N/A
NUSA:CA NBI Active U.S. Equity ET.. 3.52 % 0.00 %

+0.36 (+0.85%)

CAD 0.06B
WH2E:XETRA Invesco S&P World Health .. 3.35 % 0.00 %

+0.14 (+0.85%)

N/A
AGNG Global X Aging Population.. 3.31 % 0.00 %

+0.52 (+0.85%)

USD 0.05B
BRIF NEOS ETF Trust 3.28 % 0.00 %

+0.20 (+0.85%)

N/A
FDV First Trust Capital Stren.. 3.17 % 0.00 %

+0.15 (+0.85%)

N/A
ZPDH:F SPDR S&P U.S. Health Care.. 3.15 % 0.00 %

N/A

USD 0.40B
IUHC:SW iShares S&P 500 Health Ca.. 3.12 % 0.00 %

+0.34 (+0.85%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.11 % 0.00 %

+0.56 (+0.85%)

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 3.07 % 0.00 %

+70.50 (+0.85%)

USD 0.65B
XUHC:LSE Xtrackers MSCI USA Health.. 3.07 % 0.00 %

+1.58 (+0.85%)

USD 0.65B
SXLV:SW SPDR S&P U.S. Health Care.. 3.04 % 0.00 %

N/A

N/A
HEAL:CA 2.96 % 0.00 %

N/A

N/A
XUHC:SW 2.95 % 0.00 %

N/A

N/A
NZRO 2.90 % 0.00 %

N/A

N/A
CURE:AU ETFS S&P Biotech ETF 2.78 % 0.00 %

+0.68 (+0.85%)

USD 0.04B
WTD9:F WisdomTree US Equity Inco.. 2.65 % 0.00 %

+0.15 (+0.85%)

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 2.65 % 0.00 %

+0.23 (+0.85%)

USD 1.16M
WTEU:F WisdomTree US Equity Inco.. 2.65 % 0.00 %

+0.11 (+0.85%)

USD 0.11B
UVDV 2.35 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.33 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.20 % 0.00 %

N/A

N/A
CURE Direxion Daily Healthcare.. 2.00 % 1.06 %

+3.04 (+0.85%)

USD 0.12B
USRI:LSE 1.80 % 0.00 %

N/A

N/A
XLVE:CA 1.72 % 0.00 %

N/A

N/A
ZDY.U:CA 1.63 % 0.33 %

N/A

N/A
HYLG 1.45 % 0.00 %

N/A

N/A
LESW:LSE 1.25 % 0.00 %

N/A

N/A
QQEQ:CA Invesco NASDAQ 100 Equal .. 1.15 % 0.00 %

+0.22 (+0.85%)

CAD 0.01B
XAMB:F Amundi Index Solutions - .. 1.14 % 0.00 %

+2.40 (+0.85%)

N/A
SF1CHA:SW 1.09 % 0.00 %

N/A

N/A
F1ESG:SW UBS(Lux)Fund Solutions .. 1.09 % 0.00 %

+0.03 (+0.85%)

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

+4.31 (+0.85%)

USD 0.40B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

+2.31 (+0.85%)

USD 0.06B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

-1.28 (0.85%)

USD 3.28M
DDM ProShares Ultra Dow30 0.00 % 0.95 %

+1.50 (+0.85%)

N/A
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

+0.72 (+0.85%)

N/A
DIA SPDR Dow Jones Industrial.. 0.00 % 0.17 %

+3.51 (+0.85%)

N/A
DJD Invesco Dow Jones Industr.. 0.00 % 0.09 %

+0.56 (+0.85%)

N/A
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

+3.82 (+0.85%)

N/A
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

+0.84 (+0.85%)

USD 2.70B
FTLS First Trust Long/Short Eq.. 0.00 % 1.59 %

+0.34 (+0.85%)

USD 1.88B
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+3.34 (+0.85%)

USD 6.00B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+0.74 (+0.85%)

N/A
LABS 0.00 % 0.45 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

+4.00 (+0.85%)

USD 0.66B
LNGR 0.00 % 0.50 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

+1.55 (+0.85%)

N/A
QQEW First Trust NASDAQ-100 Eq.. 0.00 % 0.60 %

+1.14 (+0.85%)

USD 1.81B
QQXT First Trust NASDAQ-100 Ex.. 0.00 % 0.60 %

+0.97 (+0.85%)

USD 0.11B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.49 (+0.85%)

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.29 (+0.85%)

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.17 (+0.85%)

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.28 (+0.85%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.27 (0.85%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.27 (0.85%)

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.99 (+0.85%)

N/A
SICK 0.00 % 0.95 %

N/A

N/A
UDOW ProShares UltraPro Dow30 0.00 % 0.95 %

+1.92 (+0.85%)

USD 0.59B
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+3.31 (+0.85%)

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

+2.21 (+0.85%)

N/A
XLV Health Care Select Sector.. 0.00 % 0.13 %

+1.67 (+0.85%)

USD 37.98B
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

+0.57 (+0.85%)

N/A
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

+0.10 (+0.85%)

N/A
CIND:LSE iShares VII PLC - iShares.. 0.00 % 0.00 %

+12.84 (+0.85%)

USD 1.59B
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+16.13 (+0.85%)

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+0.30 (+0.85%)

N/A
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+15.00 (+0.85%)

N/A
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

+0.31 (+0.85%)

USD 2.40B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+1.14 (+0.85%)

N/A
VMVL:LSE 0.00 % 0.00 %

N/A

N/A
WQDS:LSE iShares MSCI World Qualit.. 0.00 % 0.00 %

+10.75 (+0.85%)

N/A
WQDV:LSE iShares MSCI World Qualit.. 0.00 % 0.00 %

+0.15 (+0.85%)

N/A
XLDX:LSE Xtrackers LevDAX Daily Sw.. 0.00 % 0.00 %

+824.00 (+0.85%)

N/A
EXI3:F iShares Dow Jones Industr.. 0.00 % 0.00 %

+8.20 (+0.85%)

N/A
GNAR:F 0.00 % 0.00 %

N/A

N/A
MJMT:F Amundi Index Solutions - .. 0.00 % 0.00 %

+1.48 (+0.85%)

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.07 (+0.85%)

N/A
QDVW:F iShares MSCI World Qualit.. 0.00 % 0.00 %

+0.08 (+0.85%)

N/A
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 0.85B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.24 (+0.85%)

USD 0.52B
EXI3:XETRA iShares Dow Jones Industr.. 0.00 % 0.00 %

+8.25 (+0.85%)

USD 0.30B
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
VMVL:XETRA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
ESNG 0.00 % 0.00 %

N/A

N/A
FBT:LSE First Trust Global Funds .. 0.00 % 0.00 %

+51.90 (+0.85%)

USD 8.62M
FBTU:LSE First Trust Global Funds .. 0.00 % 0.00 %

+0.86 (+0.85%)

USD 8.52M
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

+0.60 (+0.85%)

USD 0.04B
WELG:XETRA Amundi S&P Global Health .. 0.00 % 0.00 %

+0.27 (+0.85%)

N/A
WELS:XETRA Amundi S&P Global Health .. 0.00 % 0.00 %

+0.24 (+0.85%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.72% 80% B- 89% A-
Dividend Return 0.91% 67% D+ 58% F
Total Return 10.64% 80% B- 90% A-
Trailing 12 Months  
Capital Gain 7.00% 70% C- 75% C
Dividend Return 3.42% 50% F 64% D
Total Return 10.41% 70% C- 77% C+
Trailing 5 Years  
Capital Gain 31.02% 57% F 59% D-
Dividend Return 18.10% 60% D- 54% F
Total Return 49.12% 71% C- 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.14% 90% A- 60% D-
Dividend Return 10.18% 100% F 62% D
Total Return 3.04% 60% D- 67% D+
Risk Return Profile  
Volatility (Standard Deviation) 14.56% 80% B- 84% B
Risk Adjusted Return 69.88% 90% A- 87% B+
Market Capitalization 107.37B 88% B+ 100% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 40.66 43% 24%
Price/Book Ratio 27.95 13% 5%
Price / Cash Flow Ratio 14.35 38% 20%
Price/Free Cash Flow Ratio 15.90 38% 23%
Management Effectiveness  
Return on Equity 67.55% 100% 98%
Return on Invested Capital 9.85% 71% 75%
Return on Assets 6.40% 75% 88%
Debt to Equity Ratio 962.21% 17% 2%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.